Related Articles
Cetuximab retreatment in patients with metastatic colorectal cancer who exhibited a clinical benefit in response to prior cetuximab: A retrospective study
Short‑course bortezomib‑based retreatment for patients with multiple myeloma who had received bortezomib‑thalidomide‑dexamethasone (VTD) as an initial therapy: A single‑center case series
RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G0/G1 arrest only in serum starved cells
Immunohistochemical study on primary and recurrent tumors in patients with local recurrence in the conserved breast.
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis